NCT05306457View on ClinicalTrials.gov

CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 8, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

CNS10-NPC-GDNF

Unilateral injections of CNS10-NPC-GDNF into the motor cortex

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

California Institute for Regenerative Medicine (CIRM)

OTHER

lead

Cedars-Sinai Medical Center

OTHER